Search Results - "Martínez Yélamos, A"

Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases by Bruna, J, Martínez-Yélamos, S, Martínez-Yélamos, A, Rubio, F, Arbizu, T

“…Objective The Transverse Myelitis Consortium Working Group has proposed new diagnostic criteria for idiopathic acute transverse myelitis (ATM). We reviewed…”
Get full text

14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis by MARTINEZ-YELAMOS, A, SAIZ, A, SANCHEZ-VALLE, R, CASADO, V, RAMON, J. M, GRAUS, F, ARBIZU, T

“…Axonal damage probably occurs early in the evolution of MS. Five of 38 (13%) patients had a positive assay for the neuronal 14-3-3 protein in the CSF obtained…”
Get full text

Outcomes After Direct Thrombectomy or Combined Intravenous and Endovascular Treatment Are Not Different by Abilleira, Sònia, Ribera, Aida, Cardona, Pedro, Rubiera, Marta, López-Cancio, Elena, Amaro, Sergi, Rodríguez-Campello, Ana, Camps-Renom, Pol, Cánovas, David, de Miquel, Maria Angels, Tomasello, Alejandro, Remollo, Sebastian, López-Rueda, Antonio, Vivas, Elio, Perendreu, Joan, Gallofré, Miquel, Martí-Fàbregas, J, Delgado-Mederos, R, Martínez-Domeño, A, Marín, R, Roquer, J, Ois, Á, Jiménez-Conde, J, Guimaraens, L, Chamorro, Á, Obach, V, Urra, X, Macho, J.M, Blasco, J, San Roman, L, Martínez-Yélamos, A, Quesada, H, Lara, B, Cayuela, N, Aja, L, Mora, P, Molina, C, Ribó, M, Pagola, J, Rodríguez-Luna, D, Muchada, M, Coscojuela, P, Dávalos, A, Millán, M, Pérez de la Ossa, N, Gomis, M, Dorado, L, Castaño, C, Garcia, M.C, Estela, J, Krupinski, J, Huertas-Folch, S, Nicolás-Herrerias, M.C, Gómez-Choco, M, García, S, Martínez, R, Sanahuja, J, Purroy, F, Serena, J, Castellanos, M, Silva, Y, Marés, R, Pellisé, A, Ustrell, X, Baiges, J.J, Garcés, M, Saura, J, Soler-Insa, J.M, Aragonés, J.M, Cocho, D, Palomeras, E

“…BACKGROUND AND PURPOSE—Whether intravenous thrombolysis adds a further benefit when given before endovascular thrombectomy (EVT) is unknown. Furthermore,…”
Get full text

An approach to estimating the intangible costs of multiple sclerosis according to disability in Catalonia, Spain by Casado, V., Romero, L., Gubieras, L., Alonso, L., Moral, E., Martinez-Yelamos, S., Martinez-Yelamos, A., Carmona, O., Arbizu, T.

“…Multiple sclerosis (MS) is a chronic demyelinating disease, which represents a great economic burden to society. Cost-of-illness studies of MS tend to…”
Get full text

Access to Endovascular Treatment in Remote Areas: Analysis of the Reperfusion Treatment Registry of Catalonia by Pérez de la Ossa, Natalia, Abilleira, Sònia, Dorado, Laura, Urra, Xabier, Ribó, Marc, Cardona, Pere, Giralt, Eva, Martí-Fàbregas, Joan, Purroy, Francisco, Serena, Joaquín, Cánovas, David, Garcés, Moisés, Krupinski, Jurek, Pellisé, Anna, Saura, Júlia, Molina, Carlos, Dávalos, Antoni, Gallofré, Miquel

“…BACKGROUND AND PURPOSE—Since demonstration of the benefit of endovascular treatment (EVT) in acute ischemic stroke patients with proximal arterial occlusion,…”
Get full text

CSF 14-3-3 protein assay and MRI as prognostic markers in patients with a clinically isolated syndrome suggestive of MS by Martínez-Yélamos, A, Rovira, A, Sánchez-Valle, R, Martínez-Yélamos, S, Tintoré, M, Blanco, Y, Graus, F, Montalban, X, Arbizu, T, Saiz, A

Get full text

Clinical benefits of interferon beta-1a in relapsing-remitting MS: a phase IV study by Fernández, O., Arbizu, T., Izquierdo, G., Martínez-Yélamos, A., Gata, J. M., Luque, G., De Ramón, E.

“…Objective – To evaluate the efficacy and safety of IFNβ‐1a (Avonex®, Biogen, Inc., Cambridge, MA, USA) in patients with relapsing–remitting multiple sclerosis…”
Get full text

Effects of bihemispheric tDCS combined with radial nerve stimulation in acute stroke patients by Yagüe, S, Veciana, M, Pedro, J, Martínez-Yélamos, A, Kumru, H, Cardona, P, Lara, B, García, B, Montero, J, Valls-Sole, J

Get full text

P394: EEG pattern related with the administration of ketamine in the treatment of refractory status epilepticus mimicking extreme delta brush: a case report by Lazo La Torre, C, Vicente Rasoamalala, M, Lainez Samper, E, Rossich Verdes, R, Veciana de las Heras, M, Moreno Gómez, I, Martínez Yélamos, A

Get full text

Clinicopathologic features and outcomes of neuro-Behçet disease in Spain: A study of 20 patients by Riera-Mestre, A, Martínez-Yelamos, S, Martínez-Yelamos, A, Ferrer, I, Pujol, R, Vidaller, A

“…Abstract Background To describe the clinical characteristics and evolution of a series of adult patients hospitalized for neuro-Behçet disease (NBD). Methods…”
Get full text

Regression to the mean in multiple sclerosis by Martínez-Yélamos, S, Martínez-Yélamos, A, Ozaeta, G Martín, Casado, V, Carmona, O, Arbizu, Tx

“…In order to ensure sufficient disease activity, patients with relapsing remitting (RR) multiple sclerosis (MS) are often included in randomized…”
Get full text

Access to orphan drugs for the treatment of spinal muscular atrophy in Spain by García-Parra, B, Guiu, J M, Modamio, P, Martínez-Yélamos, A, Mariño-Hernández, E L, Povedano, M

“…Spinal muscular atrophy (SMA) is a rare disease whose diagnosis and treatment are complex. In Spain, there are two orphan medicines that are currently financed…”
Get full text

Geographic dissemination of endovascular stroke thrombectomy in Catalonia within the 2011–2015 period by Abilleira, Sònia, Tebé, Cristian, de la Ossa, Natalia Pérez, Ribó, Marc, Cardona, Pere, Urra, Xabier, Giralt-Steinhauer, Eva, Cánovas, David, Camps-Renom, Pol, Gallofré, Miquel

“…Introduction Endovascular thrombectomy was recently established as a new standard of care in acute ischemic stroke patients with large artery occlusions. Using…”
Get full text

Immunosuppressive therapy for pharmacoresistant epilepsy due to primary antiphospholipid syndrome by Falip, M, Miró, J, Jaraba, S, Cusó, S, Capdevila, O, Graus, F, Martínez-Yélamos, A

Get full text

Diagnostic accuracy of behavioral variant frontotemporal dementia consortium criteria (FTDC) in a clinicopathological cohort by Balasa, Mircea, Gelpi, Ellen, Martín, Idaira, Antonell, Anna, Rey, Ma Jesus, Grau-Rivera, Oriol, Molinuevo, José Luis, Sánchez-Valle, Raquel, Lladó, Albert

“…Aims The aims of this study were to assess the sensitivity of the International Behavioural Variant FTD Criteria Consortium (FTDC) revised criteria of…”
Get full text

Axonal damage in multiple sclerosis by Arbizu-Urdiain, T, Martínez-Yélamos, A

“…The presence of axonal lesions in plaques of demyelination in patients with multiple sclerosis (MS) has been known for many years. Traditionally it was…”
Get full text

Clinical benefits of interferon beta-1a in relapsing-remitting MS: a phase IV study: Clinical benefits of INFβ-1a in RRMS by Fernández, O., Arbizu, T., Izquierdo, G., Martínez-Yélamos, A., Gata, J. M., Luque, G., De Ramón, E.

Get full text

The costs of a multiple sclerosis relapse in Catalonia (Spain) by Casado, V, Martinez-Yelamos, S, Martinez-Yelamos, A, Carmona, O, Alonso, L, Romero, L, Moral, E, Arbizu, T

“…The objective of this study is to calculate direct, indirect and intangible costs of a relapse in multiple sclerosis (MS) in our cohort of patients. Data from…”
Get more information

The social and work-related impact of multiple sclerosis by Martínez Yélamos, S, Martínez Yélamos, A, Hernández Regadera, J J, Martín Ozaeta, G, Arbizu Urdiain, T

“…To analyse the repercussion of the disease in social and occupational status of multiple sclerosis patients. To describe the frequency with these patients are…”
Get more information

Immunosuppressive therapy for pharmacoresistant epilepsy due to primary antiphospholipid syndrome by Falip, M, Miró, J, Jaraba, S, Cusó, S, Capdevila, O, Graus, F, Martínez-Yélamos, A

Get full text